Cases & Deals

  • Home
  • Practices
  • Nanobiotix completes $113.3 million IPO on Nasdaq

Share

Nanobiotix completes $113.3 million IPO on Nasdaq

December 2020

Client(s) Nanobiotix

Jones Day represented Nanobiotix S.A., a French clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, in connection with its $113.3 million initial public offering in the United States and listing on Nasdaq.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.